# FDA 483 - WestChina-Frontier PharmaTech Co, Ltd - July 25, 2025

Source: https://www.globalkeysolutions.net/records/483/westchina-frontier-pharmatech-co-ltd/82e1ae02-e37d-42ba-a02d-2f7726145dd8

> FDA 483 for WestChina-Frontier PharmaTech Co, Ltd on July 25, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: WestChina-Frontier PharmaTech Co, Ltd
- Inspection Date: 2025-07-25
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of WestChina-Frontier PharmaTech Co., Ltd. in Chengdu, China, revealed significant Good Laboratory Practice (GLP) deficiencies. The firm failed to ensure timely archiving of study materials and related correspondence. Additionally, the quality assurance unit did not properly document deviations from approved protocols.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/zhou-chen/03362438-eba1-4010-b6b1-5cccf25a824c)
- [issuing_officer](https://www.globalkeysolutions.net/people/kathryn-l-suttling/2d4695ca-5ec3-4658-8f46-101cec4ca41d)
- [other](https://www.globalkeysolutions.net/people/erin-m-mcdowell/7f3995e6-5596-4b3a-a99b-27d49d4b890e)

Company: https://www.globalkeysolutions.net/companies/westchina-frontier-pharmatech-co-ltd/71492633-9779-42f1-86dd-d196dd99e1dd

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8